Metabolic Factors Associated with Incidence of Benign Prostatic Hyperplasia in Korea: Using National Health Insurance Service Data
Journal of Health Informatics and Statistics. 2020;45(4):418-425 
The Benign Prostatic Hyperplasia Incidence Rate in Korea: Using National Health Insurance Service Data
Journal of Health Informatics and Statistics. 2018;43(3):217-222
Metabolic Factors Associated with Benign Prostatic Hyperplasia
Yearbook of Urology. 2007;2007:89-90
Free combination of dutasteride plus tamsulosin for the treatment of benign prostatic hyperplasia in South Korea: Analysis of drug utilization and adverse events using the National Health Insurance Review and Assessment Service database
. 2021;
The Prevalence of Benign Prostate Hyperplasia in Korea: Using National Health Insurance Service Data
Journal of Health Informatics and Statistics. 2018;43(3):208-216
Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan
BMC Cancer. 2013;13(1):
Assessing burden of benign prostatic hyperplasia in a National Health Service: A real-world data analysis
European Urology. 2021;79:S55-S56
Comparison of Costs Associated with Turp and Prostatic Urethral Lift for Benign Prostatic Hyperplasia
Value in Health. 2018;21:S268
Benign prostatic hyperplasia: dietary and metabolic risk factors
International Urology and Nephrology. 2008;40(3):649-656
Free combination of dutasteride plus tamsulosin for the treatment of benign prostatic hyperplasia in South Korea: analysis of drug utilization and adverse events using the National Health Insurance Review and Assessment Service database
BMC Urology. 2021;21(1):